📰 Generic Formulations News
Page 2 - Generic Formulations News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Generic Formulations. Real-time updates on events, politics, business and more.
February 14, 2023
With a market capitalization of ₹28,202.09 Cr, Biocon Ltd. is a large-cap company that engages in the pharmaceutical industry.
November 15, 2022
Bengaluru (Karnataka) [India], November 15 (ANI/NewsVoir): Biocon Ltd. (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company, today announced its consolidated financial results for the second quarter ended September 30, 2022. Leadership Comments Biocon Group "We reported a strong consolidated revenue growth of 23 per cent YoY for Q2FY23 at Rs. 2,384 Crore driven by 34 per cent growth in Biosimilars, 26 per cent in Research Services and 18 per cent in the Gener...
July 29, 2021
Share this article Share this article PITTSBURGH and BENGALURU, India, July 28, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) and Biocon Biologics Ltd. (a subsidiary of Biocon Ltd.) today announced that the U.S. Food and Drug Administration (FDA) has approved Semglee ® (insulin glargine-yfgn) injection as the first interchangeable biosimilar product under the 351(k) regulatory pathway. Biocon Biologics Viatris CEO Michael Goettler commented: "We are extremely proud to achieve the industrys...